Literature DB >> 11527983

Negative regulation of cytokine signaling.

C J Greenhalgh1, D J Hilton.   

Abstract

Cytokines use complex signaling cascades to elicit their biological effects, many of which involve phosphorylation as a mechanism of activation. Rapid and efficient attenuation of cytokine signals is crucial to maintaining regulation of these processes and to preventing toxic side effects. Phosphatases have been shown to be involved in these regulatory processes, but more recent research has seen the discovery of two new families of negative regulators, the suppressor of cytokine signaling (SOCS) and protein inhibitors of signal transducer and activator of transcription (STAT) (PIAS) protein families. SOCS proteins are induced by and inhibit many cytokine-signaling systems in a classic negative-feedback loop, and the generation of transgenic and knockout models has greatly increased our understanding of their physiological functions. PIAS proteins interact with the transcriptional mediators of cytokine action, the STATs, to suppress their DNA-binding activity. These three classes of molecules form what is now emerging as an integrated system for deactivating cytokine signaling at a number of levels, from the receptor to the transcription factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527983

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  66 in total

Review 1.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

Review 2.  Lipid Metabolism in Tumor-Associated Fibroblasts.

Authors:  Hongzhong Li; Jingyuan Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

4.  SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

Authors:  Lerin R Luckett-Chastain; Michael A Ihnat; Bethany M Mickle-Kawar; Randle Michael Gallucci
Journal:  J Interferon Cytokine Res       Date:  2012-02-07       Impact factor: 2.607

5.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

6.  Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoid.

Authors:  Elena Darra; Kazuo Shoji; Sofia Mariotto; Hisanori Suzuki
Journal:  Genes Nutr       Date:  2007-10-11       Impact factor: 5.523

7.  Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

Authors:  Andrew Jarnicki; Tracy Putoczki; Matthias Ernst
Journal:  Cell Div       Date:  2010-05-17       Impact factor: 5.130

8.  Menin and RNF20 recruitment is associated with dynamic histone modifications that regulate signal transducer and activator of transcription 1 (STAT1)-activated transcription of the interferon regulatory factor 1 gene (IRF1).

Authors:  Lauren J Buro; Edmond Chipumuro; Melissa A Henriksen
Journal:  Epigenetics Chromatin       Date:  2010-09-08       Impact factor: 4.954

9.  Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells.

Authors:  Stuart J Netherton; Shirin Bonni
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

10.  MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA.

Authors:  Maikel L Colli; Fabrice Moore; Esteban N Gurzov; Fernanda Ortis; Decio L Eizirik
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.